You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis C Genotype 2

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C, Hepatitis C Virus, Compensated Cirrhosis Trial (ABT-493, ABT-530, ABT-450/r/ABT-267, ABT-333)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 8, 2021

Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

Completed
  • Hepatitis C Virus (HCV)
    • Makhachkala, Dagestan, Respublika, Russian Federation
    • +7 more
    Jun 23, 2022

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • (no location specified)
    Jul 8, 2021

    Ischemic Stroke, Transient Ischemic Attack Trial in Singapore (Genetic testing)

    Not yet recruiting
    • Ischemic Stroke
    • Transient Ischemic Attack
    • Genetic testing
    • Singapore, Singapore
      Singapore General Hospital
    Mar 9, 2023

    Hepatitis E Infection Trial in Karachi (Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli))., Isotonic Sodium Chloride

    Not yet recruiting
    • Hepatitis E Infection
    • Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli)).
    • Isotonic Sodium Chloride injection
    • Karachi, Sindh, Pakistan
      The Aga Khan University
    Mar 29, 2023

    Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

    Recruiting
    • Chronic Hepatitis C
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG
    • Sofosbuvir / Velpatasvir
    • Beijing, Beijing, China
      Peking University First Hospital
    Aug 2, 2021

    Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

    Completed
    Has Results
    • Hepatitis C Virus (HCV)
    • Glecaprevir/pibrentasvir adult formulation
    • Glecaprevir/pibrentasvir pediatric formulation
    • San Francisco, California
    • +37 more
    Sep 19, 2022

    HCV-TARGET- Hepatitis C Therapeutic Registry and Research

    Active, not recruiting
    • Hepatitis C
      • Phoenix, Arizona
      • +59 more
      Oct 5, 2022

      Chronic Hepatitis C Infection Trial in Worldwide (Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin)

      Completed
      Has Results
      • Chronic Hepatitis C Infection
      • San Francisco, California
      • +20 more
      Sep 7, 2021

      Coronary Artery Disease, Platelet Reactivity Trial (CYP2C19 genotype guided P2Y12 monotherapy, Clopidogrel)

      Not yet recruiting
      • Coronary Artery Disease
      • Platelet Reactivity
      • (no location specified)
      Mar 7, 2023

      Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

      Active, not recruiting
      • Hepatitis B, Chronic
      • Tenofovir disoproxil fumarate
      • Toronto, Ontario, Canada
        University Health Network - Toronto General Hospital
      Nov 1, 2022

      Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +3 more
      • (no location specified)
      Jul 8, 2021

      Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,

      Completed
      Has Results
      • Hepatitis C, Chronic
      • ombitasvir, paritaprevir/r, dasabuvir + ribavirin
      • ombitasvir, paritaprevir/r, dasabuvir
      • Irvine, California
      • +3 more
      Jan 21, 2021

      Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

      Recruiting
      • Hepatitis C Virus Infection, Response to Therapy of
      • Test and treat plus peer mentors
      • Usual care
      • Birmingham, Alabama
      • +3 more
      Dec 9, 2022

      HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)

      Withdrawn
      • HIV Infections
      • +2 more
      • Adefovir dipivoxil
      • +3 more
      • (no location specified)
      Oct 28, 2021

      Hepatocellular Carcinoma, Hepatitis B, Hepatitis C Trial in Duarte, Singapore (MTL-CEBPA, Sorafenib)

      Recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • Duarte, California
      • +1 more
      Feb 20, 2022

      HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin

      Terminated
      Has Results
      • HIV Infections
      • Hepatitis C
      • Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
      • +2 more
      • Birmingham, Alabama
      • +15 more
      Nov 2, 2021

      Hepatitis C, Opioid Use Disorder, IV Drug Usage Trial in Keene, Brattleboro (Mobile Tele-HCV Care, Enhanced Usual Care)

      Recruiting
      • Hepatitis C
      • +2 more
      • Mobile Tele-HCV Care
      • Enhanced Usual Care
      • Keene, New Hampshire
      • +1 more
      Jul 18, 2022

      Infection Trial in Houston (Pegylated Interferon Alfa 2a, Ribavirin, Telaprevir)

      Terminated
      Has Results
      • Infection
      • Pegylated Interferon Alfa 2a
      • +2 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 1, 2020

      Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

      Active, not recruiting
      • Hepatitis B
      • Baltimore, Maryland
      • +9 more
      Jan 17, 2023

      Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)

      Recruiting
      • Hepatitis B
      • Boston, Massachusetts
      • +3 more
      Aug 24, 2022

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

      Terminated
      • Hepatitis B, Chronic
      • Hillsborough, New Jersey
      • +11 more
      Dec 28, 2022

      HIV, Hepatitis C Trial in United States (Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a)

      Completed
      • HIV Infections
      • Hepatitis C
      • San Diego, California
      • +23 more
      Oct 28, 2021

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

      Recruiting
      • Hepatitis B, Chronic
      • Vancouver, British Columbia, Canada
      • +31 more
      Jan 17, 2023